Quarterly report · Q2
2269.TEDINET S100PI81
Period2022-04-01 → 2022-09-30
Filed2022-11-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥517.5bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Revenue | ¥1.01T | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥500.7bn | 2021-04-01 → 2021-09-30 | Cons. | Net sales |
| Operating income | ¥43.2bn | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Operating income | ¥50.3bn | 2021-04-01 → 2021-09-30 | Cons. | Operating income |
| Ordinary income | ¥43.9bn | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥94.0bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥51.8bn | 2021-04-01 → 2021-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥48.3bn | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥55.2bn | 2021-04-01 → 2021-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥33.4bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥87.5bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥36.6bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥34.9bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Net income | ¥40.0bn | 2021-04-01 → 2021-09-30 | Cons. | Profit loss |
| Total assets | ¥1.18T | at 2022-09-30 | Cons. | Assets |
| Total assets | ¥1.12T | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥1.14T | at 2021-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥426.8bn | at 2022-09-30 | Cons. | Liabilities |
| Total liabilities | ¥404.4bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥757.0bn | at 2022-09-30 | Cons. | Net assets |
| Net assets / equity | ¥713.0bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥695.7bn | at 2021-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥92.1bn | at 2022-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥67.4bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥88.7bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥64.9bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥80.9bn | at 2021-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥39.0bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥25.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥127.5bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥61.2bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥26.0bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥27.6bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥35.6bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥20.3bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥77.0bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥14.6bn | 2021-04-01 → 2021-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥237.04 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥123.31 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥607.24 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥252.54 | 2021-04-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥166.44 | 2021-07-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 60.6% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 60.3% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.4% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥292m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥292m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥786m |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥420.6bn |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥420.4bn |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥278m |
| jpcrp040300-q2r_E21902-000Foodreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥29.3bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥97.2bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥97.2bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥13m |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥14.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥517.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥517.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥292m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥44.0bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-09-30 | −¥468m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-09-30 | −¥468m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-09-30 | −¥534m |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥409.1bn |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥408.8bn |
| jpcrp040300-q2r_E21902-000Foodreportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥254m |
| jpcrp040300-q2r_E21902-000Foodreportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥39.6bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue | 2021-04-01 → 2021-09-30 | ¥92.1bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue external | 2021-04-01 → 2021-09-30 | ¥91.9bn |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥214m |
| jpcrp040300-q2r_E21902-000Pharmaceutica002reportable segment | segment profit | 2021-04-01 → 2021-09-30 | ¥11.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-09-30 | ¥501.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-09-30 | ¥500.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-09-30 | ¥468m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-09-30 | ¥50.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 561
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)EY新日本有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)高 田 慎 司 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)衣 川 清 隆 | |
| Cpa3 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)平 岡 亜 惟 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 500712000000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 517520000000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 1013092000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 51798000000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 43912000000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 93985000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 36646000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 33386000000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 87497000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 49636000000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 57323000000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 109008000000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 695703000000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 757046000000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 713021000000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 1144979000000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 1183879000000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 1117459000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 252.54 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 237.04 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 607.24 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.574 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.606 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.603 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 61186000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | 25160000000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 127526000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -35590000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -25972000000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -27614000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | 14625000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | 20269000000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -76997000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 80876000000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 88746000000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 64872000000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 166.44 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 123.31 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 148369500 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 148369500 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 148369500 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |